Tiziana Pharma »

  • Accendo Markets
    Business » Tiziana, A Possible Shining Star
    Accendo Markets - January 16, 2015, 11:41 GMT

    Tiziana Life Sciences (TILS), was established in November 2013 with the aim of developing novel therapeutics for cancer with a focus on late stage metastases. Headquarter is in London, UK. Price 51.50GBp Market cap £41.49m Source: wall street journal A broadened pipeline Tiziana Life Sciences has been granted an exclusive license to develop and commercialise